- Home
- XPON vs IMCC Comparison
XPON vs IMCC Comparison
Compare XPON & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPON | IMCC |
|---|---|---|
| Founded | 2016 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8M | 4.1M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | XPON | IMCC |
|---|---|---|
| Price | $0.71 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 237.1K | 48.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.57 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,624,939.00 | N/A |
| Revenue This Year | $61.26 | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.60 | $0.65 |
| 52 Week High | $5.50 | $7.12 |
Technical Indicators
Market Signals| Indicator | XPON | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 44.60 | 27.98 |
| Support Level | $0.67 | N/A |
| Resistance Level | $0.95 | $1.55 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 57.53 | 16.27 |
Price Performance
Historical ComparisonAbout XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.